Acetyl chloride → (R)-6-(7-acetyl-3-oxa-7,9-diaza-bicyclo[3.3.1]non-9-ylmethyl)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydro-pyrimidine-5-carboxylic acid methyl ester
Reaction equation
[CH3:1][O:2][C:3]([C:5]1[C@H:6]([C:26]2[CH:31]=[CH:30][C:29]([F:32])=[CH:28][C:27]=2[Cl:33])[N:7]=[C:8]([C:21]2[S:22][CH:23]=[CH:24][N:25]=2)[NH:9][C:10]=1[CH2:11][N:12]1[CH:17]2[CH2:18][NH:19][CH2:20][CH:13]1[CH2:14][O:15][CH2:16]2)=[O:4].C(N(CC)CC)C.[C:41](Cl)(=[O:43])[CH3:42]>C(Cl)Cl>[CH3:1][O:2][C:3]([C:5]1[C@H:6]([C:26]2[CH:31]=[CH:30][C:29]([F:32])=[CH:28][C:27]=2[Cl:33])[N:7]=[C:8]([C:21]2[S:22][CH:23]=[CH:24][N:25]=2)[NH:9][C:10]=1[CH2:11][N:12]1[CH:13]2[CH2:20][N:19]([C:41](=[O:43])[CH3:42])[CH2:18][CH:17]1[CH2:16][O:15][CH2:14]2)=[O:4]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
To a solution of (R)-4-(2-chloro-4-fluoro-phenyl)-6-(3-oxa-7,9-diaza-bicyclo[3.3.1]non-9-ylmethyl)-2-thiazol-2-yl-1,4-dihydro-pyrimidine-5-carboxylic acid methyl ester (Compound AC) (50 mg, 0.1 mmol) and triethylamine (0.042 mL, 0.3 mmol) in CH2Cl2 (5 mL) was added acetyl chloride (16 mg, 0.2 mmol) dropwise at ice-bath. The mixture was stirred at 0° C. for 2 hours. The mixture was concentrated in vacuo. The residue was extracted with ethyl acetate (20 mL×2) and then washed with saturated aqueous sodium bicarbonate solution (20 mL×2). The organic layer was dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue was purified by prep-HPLC to afford (R)-6-(7-acetyl-3-oxa-7,9-diaza-bicyclo[3.3.1]non-9-ylmethyl)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydro-pyrimidine-5-carboxylic acid methyl ester (Example 15) as a light yellow solid (45 mg).
Workup
- concentrationThe mixture was concentrated in vacuo
- extractionThe residue was extracted with ethyl acetate (20 mL×2)
- washwashed with saturated aqueous sodium bicarbonate solution (20 mL×2)
- dry with materialThe organic layer was dried over anhydrous sodium sulfate
- concentrationconcentrated in vacuo
- customThe residue was purified by prep-HPLC
Sources & evidence
- ORD record
- ord-61556b95809a4ca8ac0465ee5e8c1ba8
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09266904B2
Reaction notes
Loading…